SG11202103370RA - IMMUNOASSAY AND MEASUREMENT REAGENT FOR LEUCINE-RICH α2 GLYCOPROTEIN - Google Patents

IMMUNOASSAY AND MEASUREMENT REAGENT FOR LEUCINE-RICH α2 GLYCOPROTEIN

Info

Publication number
SG11202103370RA
SG11202103370RA SG11202103370RA SG11202103370RA SG11202103370RA SG 11202103370R A SG11202103370R A SG 11202103370RA SG 11202103370R A SG11202103370R A SG 11202103370RA SG 11202103370R A SG11202103370R A SG 11202103370RA SG 11202103370R A SG11202103370R A SG 11202103370RA
Authority
SG
Singapore
Prior art keywords
immunoassay
glycoprotein
leucine
rich
measurement reagent
Prior art date
Application number
SG11202103370RA
Inventor
Shigeo Takayama
Tetsuji Naka
Satoshi Serada
Original Assignee
Sekisui Medical Co Ltd
National Institutes Of Biomedical Innovation Health And Nutrition
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd, National Institutes Of Biomedical Innovation Health And Nutrition filed Critical Sekisui Medical Co Ltd
Publication of SG11202103370RA publication Critical patent/SG11202103370RA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47—Scattering, i.e. diffuse reflection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/59—Transmissivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38—Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11202103370RA 2018-10-09 2019-10-08 IMMUNOASSAY AND MEASUREMENT REAGENT FOR LEUCINE-RICH α2 GLYCOPROTEIN SG11202103370RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018190905 2018-10-09
PCT/JP2019/039564 WO2020075691A1 (en) 2018-10-09 2019-10-08 METHOD AND ASSAY REAGENT FOR IMMUNOASSAY OF LEUCINE-RICH α2 GLYCOPROTEIN

Publications (1)

Publication Number Publication Date
SG11202103370RA true SG11202103370RA (en) 2021-05-28

Family

ID=70164914

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103370RA SG11202103370RA (en) 2018-10-09 2019-10-08 IMMUNOASSAY AND MEASUREMENT REAGENT FOR LEUCINE-RICH α2 GLYCOPROTEIN

Country Status (7)

Country Link
US (1) US20210382041A1 (en)
EP (1) EP3865873A4 (en)
JP (1) JP7421711B2 (en)
KR (1) KR20210073546A (en)
CN (1) CN112888946A (en)
SG (1) SG11202103370RA (en)
WO (1) WO2020075691A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112964869B (en) * 2021-02-01 2022-12-09 深圳市希莱恒医用电子有限公司 Kit and detection system for detecting anti-cyclic citrullinated peptide antibody
CN117192134A (en) * 2023-09-14 2023-12-08 宁波美康盛德生物科技有限公司 Detection kit and detection method for oxidized low-density lipoprotein

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350677A (en) * 1976-11-22 1982-09-21 Massachusetts Institute Of Technology Reagent for optimizing agglutination
JP2001004623A (en) * 1999-06-23 2001-01-12 A & T:Kk Immunoassay for age-hemoglobin
AU2005231107B8 (en) * 2004-03-30 2011-04-14 Global Life Sciences Solutions Usa Llc Lateral flow format, materials and methods
US7416850B2 (en) * 2006-01-25 2008-08-26 Jemmerson Ronald R Cytochrome c and leucine-rich alpha-2-glycoprotein-1 assays, methods and antibodies
US20100190662A1 (en) * 2007-01-26 2010-07-29 Rebecca Sutphen Methods and materials for detection, diagnosis and management of ovarian cancer
JP5246709B2 (en) 2009-06-09 2013-07-24 独立行政法人医薬基盤研究所 Biomarker for testing autoimmune disease and testing method
MX2011003927A (en) 2009-07-21 2011-07-20 Sekisui Medical Co Ltd Insulin measurement method.
CA2831398C (en) * 2011-03-28 2020-06-09 Sekisui Medical Co., Ltd. Psa assay and reagent therefor
KR101974230B1 (en) * 2011-05-23 2019-04-30 세키스이 메디칼 가부시키가이샤 Method for inhibiting non-specific reaction in pivka-ii measurement reagent
WO2013100146A1 (en) * 2011-12-28 2013-07-04 積水メディカル株式会社 Latex particles for measuring particle agglomeration
CN104655851B (en) * 2013-11-22 2018-08-17 广州瑞博奥生物科技有限公司 A kind of simultaneous quantitative detects the antibody chip kit of multiple receptors
JP6862845B2 (en) * 2016-01-22 2021-04-21 日立化成ダイアグノスティックス・システムズ株式会社 Method for measuring soluble interleukin-2 receptor and reagent for measurement
WO2018062557A1 (en) * 2016-09-30 2018-04-05 積水化学株式会社 Latex particles for measurement reagent, sensitized latex particles, and measurement reagent for immunonephelometry
WO2018088455A1 (en) * 2016-11-10 2018-05-17 国立大学法人千葉大学 Diagnostic agent for sepsis
JP7185895B2 (en) * 2017-06-28 2022-12-08 学校法人 岩手医科大学 Diagnostic techniques for neonatal or perinatal infections

Also Published As

Publication number Publication date
EP3865873A4 (en) 2022-07-06
US20210382041A1 (en) 2021-12-09
WO2020075691A1 (en) 2020-04-16
CN112888946A (en) 2021-06-01
EP3865873A1 (en) 2021-08-18
KR20210073546A (en) 2021-06-18
JPWO2020075691A1 (en) 2021-09-02
JP7421711B2 (en) 2024-01-25

Similar Documents

Publication Publication Date Title
HRP20190026T1 (en) Assays for detecting the presence or amount of an anti-drug antibody
IL281102A (en) Testing for particulates
PL3482209T3 (en) Alpha-synuclein detection assay and method for diagnosing alpha-synucleinopathies
IL276637A (en) Methods and reagents for detecting and assessing genotoxicity
SG11202100097VA (en) Microfluidic detection chip for multi-channel rapid detection
EP3820366C0 (en) Breath analyte detection device
GB202102296D0 (en) Biomolecule analysis device
GB201808918D0 (en) Flow measurement improvement
SG11202103370RA (en) IMMUNOASSAY AND MEASUREMENT REAGENT FOR LEUCINE-RICH α2 GLYCOPROTEIN
ZA202204978B (en) Cd200r agonist antibodies and uses thereof
EP3827250C0 (en) A sample inspection system
HUE053453T2 (en) Immunoassay for whole blood samples
GB2579810B (en) Assay Analysis
GB201819508D0 (en) Non-destructive testing
IL282384A (en) Antibodies specific for glycosylated apoj and uses thereof
SG11202103373QA (en) LEUCINE-RICH α2 GLYCOPROTEIN COMPOSITION
NO20181382A1 (en) Flow measuring system
GB2576041B (en) Non-destructive testing
GB2579767B (en) Measurement device
GB201804909D0 (en) Separation measuring device
GB201812236D0 (en) An emergency biochemical test device
GB201819039D0 (en) Measurement system
NO20181375A1 (en) Flow measuring device
GB201820486D0 (en) Measuring spout
GB201812634D0 (en) non-destructive testing